RA
AGN

Rational Advisors’s Allergan plc AGN Stock Holding History

Rational Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,312
Closed -$250K – 559
2019
Q4 		$250K Buy
1,312
+570
+77% +$103K 0.12% 170
2019
Q3 		$125K Buy
742
+457
+160% +$74.5K 0.05% 276
2019
Q2 		$48K Buy
285
+247
+650% +$34.2K 0.02% 353
2019
Q1 		$6K Sell
38
-3,255
-99% -$472K ﹤0.01% 454
2018
Q4 		$440K Buy
3,293
+3,284
+36,489% +$538K 0.14% 120
2018
Q3 		$2K Hold
9
– – ﹤0.01% 480
2018
Q2 		$2K Buy
+9
New +$1.45K ﹤0.01% 442
2017
Q4 		– Sell
-9,712
Closed -$1.99M – 409
2017
Q3 		$1.99M Buy
9,712
+4,647
+92% +$1.08M 1.07% 15
2017
Q2 		$1.23M Buy
+5,065
New +$1.19M 0.77% 34
2015
Q3 		$9K Hold
34
– – ﹤0.01% 346
2015
Q2 		$10K Hold
34
– – ﹤0.01% 358
2015
Q1 		$10K Buy
+34
New +$9.69K ﹤0.01% 355
2013
Q4 		– Sell
-26,702
Closed -$3.85M – 892
2013
Q3 		$3.85M Sell
26,702
-18,948
-42% -$2.52M 0.29% 98
2013
Q2 		$5.76M Buy
+45,650
New +$5.17M 0.48% 43

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Rational Advisors's AGN Position: Q1 2020 in Review

Rational Advisors sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 1,312 shares — an estimated $250K sold.

Rational Advisors first reported a position in AGN in Q2 2013 and held it in 14 quarters. The position peaked at $5.76M in Q2 2013. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Rational Advisors reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Rational Advisors sold 1,312 Allergan plc shares in Q1 2020, an estimated $250K.
  • Rational Advisors first reported a position in Allergan plc in Q2 2013 and held it in 14 quarters.
  • Rational Advisors's Allergan plc position peaked at $5.76M in Q2 2013.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Rational Advisors's 13F filing for Q1 2020, filed 12 May 2020.